[1]
Zhang, M. et al. 2025. HBV Integration into Host Superenhancers Might Not Be a Risk Factor for Hepatocellular Carcinoma. Medinformatics. 2, 4 (Jun. 2025), 309–317. DOI:https://doi.org/10.47852/bonviewMEDIN52025080.